Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

N/ANon-phased studies

3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Other(2)

Detailed Status

Completed2

unknown2

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed240%

unknown240%

active_not_recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

active_not_recruitingnot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT03455582Not Applicable

Cognition Evolution and MRI Markers in PPMS Patients on 2 Years

Active Not Recruiting

NCT03768648Not Applicable

Cognition and MRI Markers in MS Patients With Aubagio® Treatment

Completed

NCT03692975Not Applicable

MRI Hippocampal Microstructure and Episodic Memory in Early Multiple Sclerosis

Completed

NCT05640141

Pre-demential Motoric Cognitive Risk Syndrome in Ageing Subjects

Unknown

NCT02974530

Description and Modeling of Swallowing Disorders After a Stroke

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5